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From the use of botanical plants in early human civilizations through 
synthetic chemistry and biotechnology, drug research has always 
passionate scientists creating exciting challenges to a large number of 
researchers from different fields, thus, promoting a collaborative effort 
between polymer scientists, pharmacologists, engineers, chemists and 
medical researchers. Worldwide, there is an increasing concern on health 
care that creates a major opportunity for development of new 
pharmaceutical formulations. Ageing populations worried about the 
quality of life in the older years are actively seeking for new, more 
effective and patient compliant drug delivery devices. This has been the 
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driving force for the continuous growth of the research made on delivery 
devices, which has become a powerful technique in health care. It has 
been recognized for long that simple pills or injections may not be the 
suitable methods of administration of a certain active compound. These 
medications present several problems and/or limitations, like poor drug 
bioavailability and systemic toxicity, derived essentially from 
pharmacokinetic and other carrier limitations and low solubility of the 
drugs in water. Therefore and to overcome these drawbacks, clinicians 
recommend frequent drug dosing, at high concentrations, in order to 
overcome poor drug bioavailability but causing a potential risk of 
systemic toxicity. Polymer science has open new strategies for drug 
delivery systems. This Chapter overviews of possible strategies 
involving polymer modification and processing for controlled drug 
delivery and drug delivery in tissue engineering. 
12.1   CONTROLLED DRUG DELIVERY SYSTEMS 
A controlled drug release system consists in a drug carrier capable of 
releasing the bioactive agent in a specific location at a specific rate [1]. 
The main purpose of these controlled release systems is to achieve a 
more effective therapy, i.e., a system with a delivery profile that would 
yield a high blood level of the drug over a long period of time, avoiding 
large fluctuations in drug concentration and reducing the need of several 
administrations. Furthermore, these systems often improve the drug 
performance, provide patient compliance and prolong drug stability. It is 
of particular interest the key role that materials have in the development 
of these new drug delivery systems, from polymers, to ceramics or even 
metals [2-4]. When a pharmaceutical agent is encapsulated within, or 
attached to, a polymer or lipid, drug safety and efficacy can be greatly 
improved and new therapies are possible. This has been the driving 
force for active study of the design of these materials, intelligent delivery 
systems and approaches for delivery through different administration 
routes [5]. Drug delivery systems are usually classified according to the 
mechanism that controls the release of the active compound. There are 
three primary mechanisms by which active agents can be released from a 
delivery system: diffusion, degradation (erosion, chemical reaction) or 
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swelling (solvent activation) [6,7]. Any or all of these mechanisms may 
occur in a given release system. 
Diffusion controlled systems are the most common ones. Two types 
of diffusion controlled systems have been developed, presenting the 
same basic principle: diffusion occurs when a drug or other active agent 
passes through the polymer that forms the controlled-release device. One 
type of diffusion-controlled release system corresponds to a reservoir 
device in which the bioactive compound (drug) forms a core surrounded 
by an inert diffusion barrier. These systems include membranes, 
capsules, microcapsules, liposomes and hollow fibbers. In this case, drug 
diffusion through the polymer matrix is the rate limiting step, and 
release rates are determined by the choice of polymer and its consequent 
effect on the diffusion and partition coefficient of the drug to be released 
[7]. The second type is a monolithic device in which the active substance 
is dispersed or dissolved in an inert polymer. These are possibly the 
most common devices for controlled drug delivery since they are 
relatively easy to fabricate and there is no danger of an accidental high 
dosage that could result from the rupture of the membrane on the 
reservoir device. The dosage release properties may be dependent upon 
the solubility of the drug in the polymer matrix, or in the case of porous 
matrixes also the tortuosity of the network, dependent on whether the 
drug is dispersed or dissolved in the polymer [8]. 
Biodegradable materials degrade within the body as a result of 
natural biological processes, eliminating the need to remove a drug 
delivery system after release of the active agent has been completed. 
Chemically controlled systems can be achieved using bioerodible or 
pendant chain systems, i.e., either by polymer degradation or cleavage of 
the drug from the polymer [9]. Polymer degradation can be defined as 
the conversion of a material that is insoluble in water into metabolites 
that are water soluble. In ideal bioerodible systems, the drug is 
homogeneously distributed in the polymer, just like in the matrix 
devices. As the polymer surrounding the drug is eroded, the drug is 
released. In the case of pendant chain system, the drug is covalently 
bound to the polymer and it is released by bond scission due to water or 
enzymes. Furthermore, degradation may take place through bulk 
hydrolysis, in which the polymer degrades in a fairly uniform manner 
throughout the matrix or it may occur only at the surface of the polymer, 
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resulting in a release rate that is proportional to the surface area of the 
drug delivery system [10].  
12.1.1   Particle formation/encapsulation 
Many technologies have been proposed to prepare polymeric particles 
for controlled drug release [11,12]. In particular, supercritical fluid 
technology presents many possibilities for particle formation and/or 
encapsulation. The differences between the processing techniques that 
have been reported are a result of the interactions and phase behavior of 
the active compounds with the supercritical fluid (SCF) [13-15]. A brief 
description of the main characteristics of each process is listed in Table 
12.1. 
Table 12.1. Summary of the supercritical fluid techniques for particle formation and/or 
encapsulation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In a Rapid Expansion from Saturated Solutions (RESS) process, the 
supercritical fluid acts as a solvent. In this technique, the active 
compound is dissolved in the supercritical fluid phase and the solution is 
expanded into a low pressure vessel. Although this process is highly 
advantageous as no organic solvents are involved it requires high ratios 
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gas/solute and high operating pressure and temperature, as the 
solubility of the compounds is usually low. The preparation of delivery 
systems using this technique is limited by the poor solubility of polymers 
in the fluid phase, and therefore it has not been widely used in the 
preparation of controlled delivery systems [15]. 
Supercritical Anti-Solvent (SAS) technique uses the supercritical fluid 
as an anti-solvent, taking advantage of the poor solubility of high 
molecular weight or polar compounds in SCFs. In this process the 
compound or mixture of compounds are dissolved in an organic solution 
and the SCF acts as an anti-solvent promoting the precipitation of the 
solute. The principle of the process is to decrease the solvent power of 
the liquid by the addition of an anti-solvent in which the solute is 
insoluble. This process broadens the applicability of the technique for the 
development of controlled drug delivery systems as numerous active 
compounds and polymers may be processed in a single step operation 
after determining the appropriate solvent for the mixture. Lopez-Periago 
et al. report the preparation of PMMA particles loaded with triflusal and 
the preparation of poly-lactic acid fibers by supercritical anti-solvent 
[16,17]. Furthermore SAS extends the applicability of supercritical fluid 
technology to the development of encapsulated systems. Encapsulation 
processes by supercritical precipitation techniques have been reviewed 
by Cocero et al. in a manuscript where different techniques and the 
mechanisms behind them are discussed in detail [18]. Hybrid materials 
can be prepared by co-precipitation of the active compound and the 
coating material. In this case a physical mixture of the active compound 
and drug carrier, such as polymer, is obtained and the interactions 
between them lead to a controlled release of the pharmaceutical agent. 
On the other hand, the possibility to co-precipitate different solutions 
through a co-axial nozzle has been explored and it is reported as 
Supercritical Enhanced Dispersion of Solutions (SEDS) in different 
papers [19-21]. In this case, the active compound is injected through the 
inner nozzle capillary, the polymer is injected through the middle 
capillary and the anti-solvent flows through the outer part. This nozzle 
design offers the possibility to precipitate particles of the core material in 
the matrix of the coating material, which nucleates around the first 
particles to be precipitated forming a thin shell or a capsule around the 
active ingredient. The initial concentrations of both active ingredient and 
carrier, as well as the flow ratio of the two solutions, will determine the 
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final morphology of the particles as well as the encapsulation efficiency. 
SAS processing can be carried out under mild operating conditions, i.e., 
near ambient temperatures. This technique allows the production of 
particles in the nanometer size and the particle size and morphology can 
be easily controlled. The main disadvantages are related with the 
difficulty in scaling up the process, as different thermodynamic and 
hydrodynamic effects need to be taken into account. The use of organic 
solvent represents also a disadvantage of the process, since it has to be 
rigorously controlled in the case of pharmaceutical applications and may 
be present in residual amounts in the product. 
In particles from gas saturated solutions (PASS) the supercritical fluid 
acts as a solute [22]. In this technique, the SCF is dissolved in the melted 
solution and the solution is expanded into a low pressure vessel. This 
method does not require the use of organic solvents, it can be easily 
scaled-up and has a high production capacity. Nonetheless, the high 
temperatures required to process some polymers may compromise its 
application for the processing of thermosensitive active compounds. For 
example, protein loaded lipid micro particles were produced and 
reported by Salas et al. [23]. Casettari et al. report the use of PASS for the 
development of mucoadhesive particles form chitosan and poly-lactic 
acid for gastrointestinal drug delivery [24]. Falconer et al. present a 
multivariate study on the effect of different operating conditions for the 
preparation of progesterone loaded gelucire particles and the results 
demonstrate that not only the independent variables of pressure and 
temperature influence the result but also the interaction between them 
influence the yield of the process [25]. Other examples, such as the 
encapsulation of caffeine or trans-chalcone in lipid carriers have been 
presented by Sousa et al. [36,27]. Garcia-Gonzalez et al. report the 
encapsulation of agents with different polarity by PASS and the 
encapsulation of inorganic particles for topical administration [28,29]. 
12.1.2   Impregnation 
The preparation of drug release products often necessitates the use of a 
mobile phase to dissolve and carry the drug component, which also 
swells and stretches the polymer matrix, facilitating the diffusion of the 
drug, and increasing the rate of impregnation. Conventionally, the 
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preparation of these systems involves three steps: solubilization of the 
pharmaceutical in an appropriate solvent, diffusion of the 
pharmaceutical through the polymer and elimination of the residual 
solvent. The dispersion of active compounds within a finished or semi-
finished matrix, that will serve as carrier takes advantage of the 
solubility of pharmaceutical compounds in supercritical conditions. The 
drug is dissolved in carbon dioxide and diffuses into the bulk of the 
matrix, when the system is depressurized the gas rapidly diffuses out of 
the polymer, leaving the drug absorbed or entrapped within the 
polymeric matrix and warranting the complete removal of solvent, 
without exposing polymers and drugs to high temperatures, which may 
degrade them. In Fig. 12.1, a schematic diagram of the process is 
presented. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 12.1. Schematic representation of the supercritical fluid impregnation 
process. 
Supercritical fluid impregnation is a process that requires the 
knowledge of the interactions between polymer-active compound-
supercritical fluid. Kazarian et al. [30-33] distinguish two mechanisms of 
impregnation assisted by supercritical fluids. The first mechanism 
corresponds to a simple deposition of the compound when the fluid 
leaves the swollen matrix. In this case, the solute is solubilized in carbon 
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dioxide and the polymer is exposed to this solution for a predetermined 
period followed by depressurization of the system. When the system is 
depressurised, carbon dioxide molecules quickly leave the polymer 
matrix, leaving the solute trapped inside. As reported by Kazarian et al., 
this mechanism concerns mostly solutes with a relatively high solubility 
in the fluid and it is specific to impregnations carried out on a matrix 
subjected to swelling upon exposure to supercritical fluids. The second 
effect, not specific to supercritical fluids, corresponds to chemical 
interactions (like van der Walls interactions) between the solute and the 
matrix, which would favor the preferential partitioning of the solute 
with the polymer phase [32]. 
Kikic and co-workers reviewed in 2003 the potential applications of 
polymer impregnation [34]. Since then, this technique has been 
employed in the preparation of a large number of drug delivery devices, 
which can be administered through different routes. Ophaltmic drug 
delivery systems have been developed for the treatment of diseases as 
glaucoma. Braga et al. report the development of hydrogels as 
ophthalmic drug delivery systems in which chitosan derivatives were 
impregnated with flurbiprofen and timolol maleate [35]. The same 
research group describes the preparation of therapeutic contact lenses 
after the impregnation of commercially available contact lenses with 
different active compounds [36-39]. The authors report that supercritical 
fluid impregnation does not compromise the integrity of the contact 
lenses, which provides major advantages over conventional 
impregnation techniques. The development of intraocular drug delivery 
systems has also gained attention especially in which concerns the post-
operative treatment of cataract surgery [40-42]. The preparation of 
transdermal drug delivery systems has also been reported in the 
literature. In this application the possibility to homogeneously disperse 
the active compound in the matrix, the ease of diffusion of the drug into 
the bulk of the material and the fact that no organic solvents are used is 
particularly relevant. In the work of Argemi et al. [43], transdermal 
patches were impregnated with naproxen. The membranes prepared 
have shown a sustainable drug release up to 24 h. The preparation of 
wound dressings impregnated with two natural bioactive compounds is 
another example of a drug delivery device prepared using supercritical 
solvent impregnation reported in the literature [44]. 
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Supercritical impregnation of polymeric matrices in the form of 
powders has also been widely explored. Examples of the systems 
studied and reported in the past few years are the case of 
poly(vinylpyrrolidone) impregnated with ketoprofen [45], 
hydroxypropylmethyl cellulose impregnated with indomethacin [46], 
impregnation of ibuprofen and timolol maleate in poly-(-caprolactone) 
[47,48], impregnation of paclitaxel, roxithromycin and 5-fluorouracil in 
poly-(lactic acid) particles [49-51], among others. Duarte et al. have 
compared the release of naproxen from ethylcellulose/methylcellulose 
particles prepared by different techniques [52]. Although in some cases 
the yield of supercritical fluid impregnation is not as high as the yield 
achieved by conventional techniques, such as solvent evaporation or 
soaking, the technique still presents major advantages.  
12.1.3   Molecular imprinting 
Molecular imprinting is a technique that allows the design of a precise 
macromolecular structure able to recognize specific molecules [53,54]. 
The mechanism underlying molecular imprinting is similar to the 
enzyme substrate concept. The principle of preparation of molecular 
imprinted polymers (MIPs) is schematically represented in  Fig. 12.2.  
 
 
 
 
 
 
Figure 12.2. Schematic representation of the preparation of moleculary imprinted 
polymers (MIPs). 
A network with specific conformational and structural sites is formed 
by polymerization and cross-linking of the monomer around the 
template. After polymerization, the template is leached out, providing 
macromolecular cavities for the entrapment of the particular molecule 
used. The envisaged applications for this technology greatly surpass the 
pharmaceutical field and encompass analytical applications, such as 
biosensors, immunoassays, separation media and affinity supports 
among others. Although the mechanism is relatively simple the 
optimization of is more complicated due to the contribution of several 
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variables involved in the process, such as the functional monomer(s), the 
type of cross-linker, the ratio between monomer and cross-linker and the 
ratio between monomer and template.  
The polymerization can be carried out under supercritical conditions, 
using carbon dioxide as a reaction media or following conventional 
polymerization routes. Duarte et al. have reported the preparation of 
molecularly imprinted poly(diethylene glycol dimethacrylate) with 
salicylic and acetylsalicylic acid [55]. Results indicate that the amount of 
drug impregnated is significantly higher when a template molecule is 
present during the polymerization step. Other examples of MIPs have 
been reported following the same approach and using propanolol,  
ibuprofen or flufenamic acid as model drugs [56-58]. Flufenamic acid 
was impregnated in a thermoresponsive drug delivery system, based on 
poly-isopropylacrylamide that was prepared using the molecular 
imprinting approach. This work represents a step forward in the 
development of complex delivery systems using clean technologies. In 
another work, Kobayashi et al. report the preparation of an uracil 
imprinted membrane of poly(styrene-co-maleic acid), demonstrating the 
flexibility of the technology for the preparation of different types of 
substrates [59]. 
12.1.4   Externally triggered delivery devices 
Smart drug delivery systems have been object of intense research [60-64]. 
The ability to release a bioactive compound according to a physiological 
need, in a spatio-temporal controlled manner may be the answer to 
avoid fluctuations and high concentrations of drug, which induce 
undesired side-effects. The possibility to trigger the release of the drug 
by external stimuli would be highly beneficial [62,65]. Several 
mechanisms have been described in the literature. Table 12.2 presents the 
mechanisms of action behind several external stimuli. Temperature 
sensitive drug delivery systems are by far the most widely studied. 
Particularly interesting are hydrogels containing poly(N-
isopropylacrylamide) (PNIPAAm). Hydrogels based on PNIPAAm 
present various applications from drug delivery, cell encapsulation and 
cell culture surfaces. This polymer presents, in aqueous solutions, a low 
critical solution temperature (LCST) around 32 ºC, which makes it 
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extremely interesting for applications in the biomedical field. Below the 
LCST, in aqueous solutions, it presents a flexible extended coil 
conformation, which makes it hydrophilic. Close to the LCST it becomes 
hydrophobic as polymer chains collapse and aggregate into a globular 
structure. Furthermore, copolymerization of NIPAAm with other 
monomers may change the overall hydrophilicity of the polymer. 
Conventional methods of polymerization involve the use of organic 
solvents and often require the use of cross-linking agents, which might 
be toxic. Temtem et al. have reported the successful polymerization of 
PNIPAAm in supercritical carbon dioxide [66]. The process proposed 
allows the in-situ polymerization of PNIPAAm, leading to the 
development of smart-drug delivery devices in a single step process [67].  
Table 12.2. Mechanism of action of different stimuli used as triggers for controlled drug 
release. 
External stimuli Mechanism of action 
Thermal Change in temperature – change in polymer-polymer and water-
polymer interactions – change in polymer conformation and 
solubility - change in swelling – drug release 
pH Change in pH-swelling-drug release 
Ionic strength Change in ionic strength-change concentration of ions inside drug 
delivery device – change in swelling – drug release 
Chemical species Electron donating compounds – formation of charge/transfer 
complex- change in swelling – drug release 
Enzyme mediated Change in swelling of the matrix – promotes enzyme activity over 
the substrate – degradation of the substrate by enzymatic cleavage 
- drug release 
Magnetic Applied magnetic field – changes pores in the matrix – change in 
swelling – drug release 
Electrical  Applied electrical field – membrane charging – electrophoresis of 
charged drug – change in swelling – drug release 
Ultrasound irradiation Ultrasound irradiation – temperature increase – drug release 
 
Certain polysaccharides and polymers respond to pH changes as it is 
the case of chitosan, alginate, hyaluronic acid as examples of natural 
polymers and polyacrylic acid as a synthetic pH responsive polymer 
[68]. Chitosan owes its pH sensitive behavior to the large amount of 
amino groups present in its chains and swells in acidic pH, while for 
polyacrylic acid, on the other hand, due to the presence of acidic groups 
swells in basic media. Temtem et al. refer the preparation of a dual 
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stimuli responsive matrix, based on chitosan and PNIPAAm [69]. 
Chitosan is a pH responsive polymer, while PNIPAAm is 
thermosensitive. The results demonstrate the possibility to control 
polymer swelling by either pH or temperature, and drug release can be 
modulated according to the different stimuli applied. Other examples of 
externally triggered pulse-wise drug delivery devices have been 
developed for specific applications, nonetheless supercritical fluid 
technology has, to our knowledge, not yet been reported in the 
development of such systems.  
12.2   DRUG DELIVERY IN TISSUE ENGINEERING APPLICATIONS 
The concept of tissue engineering has long surpassed the idea of a 
merely inert support for cell attachment and growth. Tissue engineering 
is a promising therapeutic approach that involves the edges of a triangle 
in which, materials, active principles and cells all play an important role 
( Fig. 12.3) [12,70-72]. 
 
 
 
 
 
 
 
 
 
 
 
Figure 12.3. Tissue engineering: a combinatory approach of biomaterials, cells 
and active compounds. 
In this sense, the preparation of delivery systems able to sustain the 
release of biologically active molecules is a major challenge. Within the 
tissue engineering field, not only a controlled release needs to be 
achieved but the polymer architecture requires very particular features 
for each given tissue [73]. 3D architectures or scaffolds should present 
adequate surface properties, both chemically and topographically, as 
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these characteristics will ultimately dictate cell adhesion to the surface. 
Furthermore, they should present adequate porosity, mean pore size and 
interconnectivity between the pores to promote cell penetration and 
assure oxygen and nutrient diffusion into the bulk of the matrix, as well 
as waste retrieval. Matrices must also have appropriate mechanical 
properties to withstand mechanical forces and maintain physical 
integrity, the materials must be biocompatible, and the degradation 
products non-cytotoxic.  
The major challenge in tissue engineering arises, in the optimization 
of polymer processing techniques [74]. A variety of different processing 
techniques have been developed and include fibre bonding, freeze 
drying, solvent casting and particle leaching, wet spinning, particle 
aggregation, electrospinning, 3D potting and supercritical fluid 
technology among others ( Fig. 12.4) [75]. The choice of the most suitable 
polymer processing technique depends greatly on the characteristics of 
the polymer itself, particularly their solubility in aqueous or organic 
solutions and their thermal properties as these will ultimately determine 
the feasibility to successfully produce matrices with the desired features. 
Processing thermosensitive bioactive compounds requires, however, the 
use of mild processing conditions and the reduction of the amount of 
organic solvents used [76,77]. This presents an increase challenge in 
materials processing for tissue engineering and regenerative medicine. 
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Figure 12.4. Summary of different polymer processing methodologies employed 
in scaffold fabrication for tissue engineering and regenerative medicine. 
The application of green technologies for the preparation of 
structures for tissue engineering has gained much attention in the past 
ten years and a number of publications have been reported describing a 
variety of different techniques aiming to pursue the development of a 
single step technology able to produce a material with all the desired 
properties. From the use of carbon dioxide as a drying agent in 
supercritical fluid drying, to the use of carbon dioxide as a plasticizing 
agent in gas foaming and sintering or the use of carbon dioxide as an 
anti-solvent in the supercritical assisted phase inversion method, almost 
all encounter a way to satisfy most of the characteristics requested. A 
summary of the features of the different technologies and some examples 
of drug delivery systems for tissue engineering and regenerative 
medicine applications are listed in Table 12.3 [78-88]. Hydrogel foaming 
is a more recent technique which has been explored for the preparation 
of porous scaffolds and in this process hydrogels foaming involves the 
dissolution of carbon dioxide in the water phase present on the hydrogel 
which will promote foaming of the structure upon depressurization 
[89,90]. Sintering is a technique which occurs at near critical conditions 
and relies on the slight plasticization of the polymer particles which are 
fused together, creating a 3D environment [91,92]. Although these 
techniques have not yet been reported for the preparation of drug 
delivery systems, their mild processing conditions foresee interesting 
developments in this field, especially in which concerns the 
impregnation of proteins, growth factors and cells. 
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Table 12.3. Summary of different supercritical-based techniques used in the preparation of 
drug delivery systems in tissue engineering applications. 
Technique Principle Examples of drug delivery systems prepared 
Foaming The polymer is exposed to 
carbon dioxide at the saturation 
pressure and temperature, 
which plasticizes the polymer 
and reduces the glass transition 
temperature. Upon 
depressurization, 
thermodynamic instability 
causes supersaturation of the 
carbon dioxide dissolved in the 
polymeric matrix, and hence, 
nucleation of the cells occurs. 
Poly(d,l-lactide) and poly(d,l-lactide-co-
glycolide) impregnated with indomethacin [78] 
Poly(methyl methacrylate)-poly(L-lactic acid) 
foams loaded with ibuprofen [79] 
Poly(D,L-lactide-co-glycolide) foams with 
encapsulated growth factors [80] 
3D architectures of poly(D,L-lactide-co-
glycolide) as vehicles for DNA delivery [81] 
Vascular endothelial growth factor encapsulated 
in PLGA scaffolds [82,83] 
Phase 
inversion 
The polymer is dissolved in an 
organic solvent and placed in 
contact with a non-solvent 
(CO2), which causes the 
solution to be phase separated, 
creating a 3D porous structure. 
Starch-poly-lactic acid blend impregnated with 
dexamethasone [84] 
Poly(vinylidene fluoride-co-
hexafluoropropylene) loaded with amoxicillin 
[85] 
Poly-methylmethacrylate loaded with amoxicilin 
[86] 
Drying Supercritical drying is a drying 
technique which does not 
compromise the integrity of the 
structure as there are no phase 
boundaries, i.e., phase 
transitions involved in the 
process. 
Chitosan matrices impregnated with 
camptothecin and griseofulvin [87] 
Chitin scaffolds loaded with dexamethasone [88] 
12.3   CONCLUSIONS 
The preparation of drug delivery systems is intimately related with 
polymer modification and the design of new processes able to produce 
systems that meet most of the requirements of an ideal delivery system. 
Different techniques, from particle formation, impregnation and 
polymerization have been explored and are reported in the literature. In 
the future the combination and integration of different techniques may 
see exciting perspectives as a single technique may not be enough for the 
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development of a drug delivery system which meets all the required 
features. The integration of different technologies could provide 
interesting developments in shaping biomaterials into various 
constructs, opening a wide range of opportunities for the preparation of 
enhanced polymeric materials as structural supports for drug delivery. 
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